Calgenex Corporation Introduces New Topical Psoriasis Treatment

Published: Sep 27, 2006

TAMPA, Fla.--(BUSINESS WIRE)--Calgenex Corporation today announced the introduction of Dermalleve, a new over-the-counter (OTC) topical drug treatment for psoriasis, eczema, and seborrheic dermatitis. Dermalleve combines maximum-strength anti-pruritic medicine with natural skin conditioners and emollients to stop the itching, reduce inflammation, and support the body’s healing process.

Back to news